Introducing the Lucid™ Robotic System

Vice President of Finance

Mahmoud brings to Neural Analytics over 25 years of finance leadership in various industries, and over 15 years in the Medical Devices Industry. His areas of expertise include strategic planning, controllership, cost management, organizational growth, process improvements, systems implementation, and helping companies grow exponentially through both organic growth and M&A. Prior to joining Neural Analytics, Mahmoud was the head of finance for the Newborn Care strategic business unit of Natus Medical, Inc where he was a member of the leadership. Prior to Natus, Mahmoud held a Sr. Director of Financial Planning at Hansen Medical where he assisted in the commercialization of the first robotic system to treat Atrial Fibrillation, a Director of Finance at Medtronic Inc., and a Director of Financial Planning and Analysis at Kyphon Inc. where he assisted in the companies exponential growth until the company was acquired by Medtronic. Prior to medical devices, Mahmoud held various finance and controllership positions at Coherent Inc, Harris Corporation, Hewlett Packard, Ampex Corporation, and IBM WTC. He holds a Bachelor of Science in Accounting and Finance, and an MBA from Pepperdine University.

Chief Product Officer

As a Senior Executive in the medical device industry, Art has a proven track record of delivering high quality, clinically impactful products.  As Chief Product Officer for Neural Analytics, Art drives the development of new products from inception through post-delivery support.  From targeted technology development through customer focused product development, Art’s responsibility is to ensure that Neural Analytics customers have best in class products to help them deliver better care to their patients. Art has over thirty years of high reliability, critical system development management experience including Class I, Class II, and Class III medical devices.  Prior to joining Neural Analytics, Art was Vice President of R&D for Stryker / Physio-Control.  Previous to Physio-Control, Art was Vice President of Engineering at FujiFilm SonoSite.  In addition to driving innovation in new products and processes, Art has been instrumental in ensuring that M&A actions are smoothly integrated into the business while maintaining and expanding innovation and development capabilities.  Art has also served in senior leadership roles in the Aerospace and Commercial Software industries. Art is a native of Washington State and has a Bachelor of Science in Electrical Engineering from the University of Washington.

Board Director

Yuri is the Managing Director of 37Ventures, a venture fund focusing on growing early-stage startups. He serves on the board of numerous companies, including Neural Analytics. Yuri has over 20 years of experience in the development, capitalization and growth of emerging technology companies. From 1993 to 2008, Yuri founded and held executive roles in Xylan, Access360, 5square, Folsom Lake Nissan. He was instrumental in driving the sale of Access360 to IBM in 2002.

Board Member

Leo is the co-founder and CEO of Neural Analytics, Inc. Prior to starting Neural Analytics in 2013, Leo was the co-founder and CTO of Custom Nanotech Consulting and Director of Nanofabrication at Nabsys. Leo earned his MBA from the UCLA Anderson School of Management in 2014 and earned his PhD & MS in Biomolecular Nanotechnology & Solid-State Device Physics as an NSF IGERT fellow at Arizona State University in 2007. He also holds a double B.S. in Electrical Engineering & Biomedical Engineering from California State University, Long Beach.

Board Director

Nick built his first company, Firefly Network, focused on developing and commercializing collaborative filtering in 1995. After selling Firefly to Microsoft in 1999, Nick co-founded one of the first ISPs, PeoplePC, which he took public and merged with Earthlink. Most recently, Nick incubated and helped build several successful startups, including Loot Crate (named Inc. magazine’s “Fastest-Growing Private Company of 2016”) and Pluto TV, a streaming web platform. He holds an MBA from Harvard Business School, an undergraduate degree from Yale, and spent his early career at Goldman Sachs and McKinsey & Company.

Board Director

Dongmei is the CEO & IC Chairman of GP Healthcare Capital Co., Ltd. and is responsible for general management. Ms. Ji has 16 years of experience working in financial institutions and over 10 years of experience in equity investment. As a part of her work at GP Capital, Dongmei invested in companies including Sinobioway Medicine and Huayu Landscape. Ms. Ji is also the board director of V-Grass. She holds a master’s degree in biology from Fudan University.

Board Director

Stanton has been Chief Scientific Officer at Edwards Lifesciences since 2008 and also serves as Corporate Vice President, Advanced Technology. Stanton joined the company in 2004, when Edwards acquired Percutaneous Valve Technologies, a company that Stanton helped to found in 1999 and at which he served as President and CEO. Previously, Mr. Rowe was Corporate Vice President of Business Development and Strategic Planning for Datascope and Vice President of Business Development for Johnson & Johnson’s Interventional Systems Division. Stanton is a member of board of directors of InSeal Medical, Ltd., as well as a board member for the Discovery Science Center in Orange County. Mr. Rowe earned his bachelor’s degree from the University of Alabama.

Board Member

Roy is the Executive Director of the UCLA Business of Science Center and a professor at the David Geffen School of Medicine at UCLA. Roy has a background in international finance, banking and real estate, and serves as director of several banks domestically and abroad. In addition, Mr. Doumani has been involved in multiple life sciences startups, including Agensys as a founder, investor and director and Kite Pharma as a founder and current director. Roy graduated from UCLA with a degree in Business and Finance and also earned a law degree from USC.